Responses to parliamentary questions
Question from Deputy Barry Ward - PQ 43302-26
Deputy Ward asked about the review by the HSE Drugs Group regarding the reimbursement of risdiplam. Read the HSE response.
From: Communications and public affairs
Published: June 2026
Updated: July 2026
Documents
Summary
To ask the Minister for Health the position regarding the decision process behind the review by the HSE Drugs Group regarding the reimbursement of risdiplam for adults living with spinal muscular atrophy (SMA); and if she will make a statement on the matter.
This is a beta version - your feedback will help us to improve it